Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09.

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

Welcome back, pals. What I’m reading: A profile of the running program in Kenya, one that includes immense talent but also a doping crisis as runners attempt to escape poverty. Send me your good reads, your running routes, and any and all health care tips: [email protected].

The faux transparency of drug prices

The entire pharmaceutical industry faced a moment of reckoning in 2017, right after President Trump was elected the first time and said drug companies were “getting away with murder” over their high prices.

STAT+ Exclusive Story

STAT+



This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe